Connect your AI

Alamar Biosciences ALMR Other Current Liabilities

Other Current Liabilities at other companies

Duke EnergyDUK

-$468M-122%

LKQLKQ

$75M+500%

FluorFLR

$0—

Keurig Dr PepperKDP

-$129M+25.4%

Silicon LaboratoriesSLAB

-$7.42M-162%

CitigroupC

$1.33B+35.9%

Other financials

Income statement

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Alamar Biosciences 's other current liabilities?: Alamar Biosciences (ALMR) reported other current liabilities of -$1.23M in Q1 2026.